Quest Diagnostics Inc. (DGX) on GreekSoup https://greeksoup.ai/stocks/us/dgx/ Every dated entry in the public record on Quest Diagnostics Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 23 Sep 2026 00:00:00 +0000 Quest Diagnostics Inc.: Davis J. E. (CEO and President) sold 10,000 shares at $242.72 on 1 September 2026, $2.4 millionhttps://greeksoup.ai/stocks/us/dgx/insiders/us:DGX:insider:2026-09-03:f924adaaeeThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc.: Form 144, Davis J. E. plans to sell 10,000 shares worth $2.4 million around 1 September 2026https://greeksoup.ai/stocks/us/dgx/planned-sales/us:DGX:planned-sale:2026-09-01:0cc91b400aTue, 01 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc.: Prevoznik Michael E (SVP & General Counsel) sold 16,010 shares at $242.88 on 28 August 2026, $3.9 millionhttps://greeksoup.ai/stocks/us/dgx/insiders/us:DGX:insider:2026-08-31:f4a3551fe6Mon, 31 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc.: Prevoznik Michael E (SVP & General Counsel) sold 6,237 shares at $243.63 on 28 August 2026, $1.5 millionhttps://greeksoup.ai/stocks/us/dgx/insiders/us:DGX:insider:2026-08-31:4b7853a380Mon, 31 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc.: Prevoznik Michael E (SVP & General Counsel) sold 430 shares at $244.51 on 28 August 2026, $105,141https://greeksoup.ai/stocks/us/dgx/insiders/us:DGX:insider:2026-08-31:2d44bc113fMon, 31 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc.: short interest 3,445,561 shares at the 31 August 2026 settlement, 3.86 days to coverhttps://greeksoup.ai/stocks/us/dgx/short-interest/us:DGX:short-interest:2026-08-31:c1703bad6cMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc.: Form 144, PREVOZNIK MICHAEL E plans to sell 22,677 shares worth $5.5 million around 28 August 2026https://greeksoup.ai/stocks/us/dgx/planned-sales/us:DGX:planned-sale:2026-08-28:456f819936Fri, 28 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc.: Schedule 13G/A filed by T. Rowe Price Associates, Inc., 4.9% of the classhttps://greeksoup.ai/stocks/us/dgx/holders/us:DGX:schedule-13:2026-08-14:1ef87d5dcaFri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc.: short interest 3,321,414 shares at the 14 August 2026 settlement, 4.67 days to coverhttps://greeksoup.ai/stocks/us/dgx/short-interest/us:DGX:short-interest:2026-08-14:be682de964Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc.: Carol Devine Miller (WV01) disclosed a sale, $15,001 - $50,000, traded 10 March 2025https://greeksoup.ai/stocks/us/dgx/congress/us:DGX:congress:2026-08-13:e38e54871eThu, 13 Aug 2026 00:00:00 +0000House tradeHouse trade. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc.: Julie Johnson (TX32) disclosed a sale, $1,001 - $15,000, traded 30 October 2025https://greeksoup.ai/stocks/us/dgx/congress/us:DGX:congress:2026-08-05:4e6282637dWed, 05 Aug 2026 00:00:00 +0000House tradeHouse trade. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc.: Julie Johnson (TX32) disclosed a purchase, $1,001 - $15,000, traded 30 October 2025https://greeksoup.ai/stocks/us/dgx/congress/us:DGX:congress:2026-08-05:8df3a75d74Wed, 05 Aug 2026 00:00:00 +0000House tradeHouse trade. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc.: short interest 3,684,192 shares at the 31 July 2026 settlement, 2.74 days to coverhttps://greeksoup.ai/stocks/us/dgx/short-interest/us:DGX:short-interest:2026-07-31:d21a625570Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc.: Delaney Mark E (SVP & Chief Commercial Officer) sold 1,600 shares at $235.18 on 28 July 2026, $376,288https://greeksoup.ai/stocks/us/dgx/insiders/us:DGX:insider:2026-07-29:81d0edfb7bWed, 29 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc.: Form 144, DELANEY MARK E plans to sell 1,600 shares worth $376,288 around 28 July 2026https://greeksoup.ai/stocks/us/dgx/planned-sales/us:DGX:planned-sale:2026-07-28:0616d45031Tue, 28 Jul 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc. Q2 FY2026 results: revenue $3.0 billion, net income $320 millionhttps://greeksoup.ai/stocks/us/dgx/results/fy2026-q2/us:DGX:result:2026-07-23:b484bf55e4Thu, 23 Jul 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/dgx/filings/us:DGX:filing:2026-07-23:e21da579c5Thu, 23 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/dgx/filings/us:DGX:filing:2026-07-23:17259f0c4fThu, 23 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc.: short interest 3,509,407 shares at the 15 July 2026 settlement, 4.26 days to coverhttps://greeksoup.ai/stocks/us/dgx/short-interest/us:DGX:short-interest:2026-07-15:adf835a633Wed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Quest Diagnostics Inc.: short interest 3,732,507 shares at the 30 June 2026 settlement, 3.84 days to coverhttps://greeksoup.ai/stocks/us/dgx/short-interest/us:DGX:short-interest:2026-06-30:2508182bcdTue, 30 Jun 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>